Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PAR PHARMACEUTICAL COS INC Analyst Recommendations

  • Analyst Consensus: PRX

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.250 Buy 8
    30 Days Ago 2.125 Buy 8
    60 Days Ago 2.125 Buy 8
    90 Days Ago 2.250 Buy 8
    120 Days Ago 2.250 Buy 8
  • Analyst Ratings: PRX

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Barclays Capital Equal Weight Overweight 10/15/2009
    RBC Capital Mkts Sector Perform 10/09/2009 21.00
    RBC Capital Mkts Sector Perform 08/21/2009 19.00
    Standpoint Research Buy Hold 08/19/2009
    Caris & Company Above Average Buy 08/19/2009 25.00
    Caris & Company Above Average 08/17/2009 20.00
    Caris & Company Buy Above Average 08/05/2009 17.00
    Caris & Company Above Average Buy 05/07/2009 17.00
    RBC Capital Mkts Sector Perform 04/22/2009 12.00
    Needham Strong Buy 03/04/2009 18.00
    Caris & Company Above Average 11/26/2008 15.00
    Caris & Company Above Average 11/20/2008 17.00
    Caris & Company Above Average 11/10/2008 15.00
    Needham Strong Buy 09/24/2008 21.00
    Stanford Research Hold 09/24/2008
    Caris & Company Average 07/01/2008 16.00
    JP Morgan Neutral Underweight 03/04/2008
    Friedman Billings Underperform 02/08/2008
    Lehman Brothers Overweight Equal-weight 12/13/2007
    Friedman Billings Mkt Perform Underperform 10/01/2007 14.00
    Friedman Billings Mkt Perform 09/10/2007 25.00
    Friedman Billings Mkt Perform 07/27/2007 29.00
    Friedman Billings Mkt Perform 07/11/2007 32.00
    Leerink Swann Mkt Perform Outperform 05/21/2007
    Lehman Brothers Overweight 03/14/2007 26.00
    Goldman Sachs Sell 01/31/2007 27.00
    Friedman Billings Mkt Perform 01/30/2007 29.00
    Lehman Brothers Overweight 11/22/2006 22.00
    Friedman Billings Outperform Mkt Perform 09/27/2006 19.00
    Goldman Sachs Neutral Sell 08/24/2006